Open Access<p>Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma</p>
Author(s) -
Xuewei Zhu,
Jianan Cong,
Lin Zhang,
Jing Sun,
Ben Yang,
Li Aipeng
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s239243
Subject(s) - ku70 , cisplatin , microbiology and biotechnology , nasopharyngeal carcinoma , dna repair , hmgb1 , chemistry , viability assay , cancer research , parp inhibitor , radioresistance , biology , cell culture , poly adp ribose polymerase , dna , cell , medicine , biochemistry , polymerase , radiation therapy , genetics , receptor , chemotherapy
This study aimed to investigate the effect of high mobility group protein B1 (HMGB1) on chemoresistance and radioresistance in nasopharyngeal carcinoma (NPC).